SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038583
Filing Date
2020-08-10
Accepted
2020-08-10 06:57:47
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q reta-10q_20200630.htm   iXBRL 10-Q 2013240
2 EX-10.1 reta-ex101_14.htm EX-10.1 18816
3 EX-10.2 reta-ex102_12.htm EX-10.2 365401
4 EX-10.3 reta-ex103_13.htm EX-10.3 572569
5 EX-10.4 reta-ex104_266.htm EX-10.4 45014
6 EX-31.1 reta-ex311_9.htm EX-31.1 20537
7 EX-31.2 reta-ex312_7.htm EX-31.2 20658
8 EX-32.1 reta-ex321_6.htm EX-32.1 10179
9 EX-32.2 reta-ex322_8.htm EX-32.2 10291
10 GRAPHIC gc5wfxbjmqdc000001.jpg GRAPHIC 38584
  Complete submission text file 0001564590-20-038583.txt   6797856

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA reta-20200630.xsd EX-101.SCH 40425
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20200630_cal.xml EX-101.CAL 36070
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20200630_def.xml EX-101.DEF 130873
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20200630_lab.xml EX-101.LAB 304557
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20200630_pre.xml EX-101.PRE 222954
16 EXTRACTED XBRL INSTANCE DOCUMENT reta-10q_20200630_htm.xml XML 785858
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 201087018
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences